Clinical Trials Logo

Clinical Trial Summary

Ischemic heart disease remains the leading cause of death in the western world. The beneficial effects of cardiac rehabilitation on the evolution of ischemic heart disease are known, but the effects of rehabilitation on the metabolic processes of the patients are so far poorly understood. Metabolomics is the qualitative/quantitative analysis of the body's metabolic responses to pathophysiological stimuli or genetic alterations. Metabolic changes caused by physical activity have been demonstrated in obese and diabetic patients and in athletes. Aim of the study is to evaluate whether cardiac rehabilitation after a first myocardial infarction induces changes in the metabolic state of patients, and whether these changes may be related with changes in the usual risk factors (i.e. glyco-lipidic profile, natriuretic peptides, homocysteine).


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06298513
Study type Observational
Source Istituto Auxologico Italiano
Contact Gianfranco Parati, MD
Phone 039 0261911
Email gianfranco.parati@unimib.it
Status Recruiting
Phase
Start date May 2, 2023
Completion date December 2025

See also
  Status Clinical Trial Phase
Completed NCT02753829 - Home-based Cardiovascular Rehabilitation, Maintenance Phase, in Subjects With Coronary Artery Disease N/A
Completed NCT01522001 - Shared Care Rehabilitation After Acute Coronary Syndrome Phase 4
Recruiting NCT02758600 - Cardiopulmonary and Metabolic Responses to Early Exercise in Patients After Coronary Arterial Bypass Grafting N/A
Completed NCT02402582 - Effect of Family-Centered Empowerment Model N/A
Withdrawn NCT02803073 - Effect of Testosterone Replacement on Exercise Capacity in Hypogonadal Men After a Recent Myocardial Infarction Phase 2/Phase 3